Cargando…
Lactate promotes the growth of patient-derived organoids from hepatopancreatobiliary cancers via ENO1/HIF1α pathway and does not affect their drug sensitivities
The long culture duration of patient-derived organoids (PDOs) have severely limited their clinical applications. The aim of this study was to determine the effect of lactate supplementation on the growth, genetic profiles and drug sensitivities of PDOs from hepatopancreatobiliary tumors. LM3, Huh7,...
Autores principales: | Wang, Zhiwei, Yu, Yuanquan, Wu, Peiyao, Ye, Qinghuang, Guo, Yinghao, Zhang, Xiaoxiao, Xi, Longfu, Li, Qi, Jin, Yun, Zhou, Donger, Luo, Yan, Peng, Shuyou, Li, Jiangtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021221/ https://www.ncbi.nlm.nih.gov/pubmed/35443744 http://dx.doi.org/10.1038/s41420-022-01014-4 |
Ejemplares similares
-
Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
por: Wang, Zhiwei, et al.
Publicado: (2021) -
Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid
por: Wang, Zhiwei, et al.
Publicado: (2021) -
Recent developments in hepatopancreatobiliary EUS
por: Cazacu, Irina M., et al.
Publicado: (2019) -
Intraoperative Imaging in Hepatopancreatobiliary Surgery
por: Husarova, Tereza, et al.
Publicado: (2023) -
Current role of trisectionectomy for hepatopancreatobiliary malignancies
por: Kron, Philipp, et al.
Publicado: (2019)